Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Jones

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
JACC. Cardiovascular Interventions|June 25, 2025
Cost-Effectiveness of Early Discharge (<48 Hours) for Low-Risk Patients Following PPCI for STEMIKrishnaraj S Rathod, Katrina Comer, Oliver Casey-Gillman, et al.
ESC Heart Failure|September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MIDavid Erlinge, Stefan James, John Deanfield, et al.
JACC. Cardiovascular Imaging|January 21, 2019
Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance StudyAnkur Gulati, Tevfik F Ismail, Aamir Ali, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Coronary Artery Disease|July 10, 2018
Outcomes after chronic total occlusion percutaneous coronary interventions: an observational study of 5496 patients from the Pan-London CTO CohortDaniel A Jones, Krishnaraj S Rathod, Antonis N Pavlidis, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart FailureAnkur Gulati, Alan G Japp, Sadaf Raza, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
JACC. Cardiovascular Interventions|July 21, 2018
Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes From the Pan-London PCI CohortDaniel A Jones, Krishnaraj S Rathod, Sudheer Koganti, et al.
Open Heart|October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trialAleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
JACC. Cardiovascular Interventions|June 25, 2025
Cost-Effectiveness of Early Discharge (<48 Hours) for Low-Risk Patients Following PPCI for STEMIKrishnaraj S Rathod, Katrina Comer, Oliver Casey-Gillman, et al.
ESC Heart Failure|September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MIDavid Erlinge, Stefan James, John Deanfield, et al.
JACC. Cardiovascular Imaging|January 21, 2019
Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance StudyAnkur Gulati, Tevfik F Ismail, Aamir Ali, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Coronary Artery Disease|July 10, 2018
Outcomes after chronic total occlusion percutaneous coronary interventions: an observational study of 5496 patients from the Pan-London CTO CohortDaniel A Jones, Krishnaraj S Rathod, Antonis N Pavlidis, et al.
Circulation. Cardiovascular Imaging|October 26, 2018
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart FailureAnkur Gulati, Alan G Japp, Sadaf Raza, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
JACC. Cardiovascular Interventions|July 21, 2018
Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes From the Pan-London PCI CohortDaniel A Jones, Krishnaraj S Rathod, Sudheer Koganti, et al.
Open Heart|October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trialAleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
Pageof 14